Role of the endocannabinoid system in alcohol-related behaviors

Open Neuropsychopharmacology Journal

Volumn 2, Issue , 2009, Pages 31-39

  Hungund, Basalingappa L ^a,b,c   Yaragudri, K Vinod ^a,b,d  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^c New York Presbyterian Columbia University Medical Center   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CANNABINOID RECEPTOR; ENDOCANNABINOID; ION CHANNEL; NEUROTRANSMITTER;

ALCOHOL ABUSE; ALCOHOL TOLERANCE; ALCOHOL WITHDRAWAL; ALCOHOLISM; BRAIN REGION; HUMAN; NONHUMAN; PRIORITY JOURNAL; RELAPSE; REVIEW; SIGNAL TRANSDUCTION;

EID: 77953444623     PISSN: None     EISSN: 18765238     Source Type: Journal    
DOI: 10.2174/1876523800902020031     Document Type: Review

References (104)

1. Watson SJ, Benson JA Jr, Joy JE. Marijuana and medicine: assessing the science base: a summary of the 1999 Institute of Medicine report. Arch Gen Psych 2000; 57: 547-552
2. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990; 346: 561-564 (Pubitemid 20238806)
3. Devane WA, Hanus L, Breuer A, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992; 258: 1946-9.
4. Wegener N, Koch M. Neurobiology and systems physiology of the endocannabinoid system. Pharmacopsychiatry 2009; 42(Suppl 1):S79-86.
5. Ahn K, McKinney MK, Cravatt BF. Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem Rev 2008; 108: 1687-1707 (Pubitemid 351796405)
6. Hungund BL, Basavarajappa BS, Vadasz C, et al. Ethanol, endocannabinoids, and the cannabinoidergic signaling system. Alcohol Clin Exp Res 2002; 26: 565-574 (Pubitemid 34408723)
7. Mackie K. Signaling via CNS cannabinoid receptors. Mol Cell Endocrinol 2008; 286: 60-65
8. Vinod KY, Hungund BL. Cannabinoid-1 receptor: a novel target for the treatment of neuropsychiatric disorders. Expert Opin Ther Targets 2006; 10: 203-210
9. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG. International Union of Pharmacol XXVII. Classification of cannabinoid receptors. Pharmacological Rev 2002; 54: 161-202.
10. Van Sickle MD, Duncan M, Kingsley PJ, et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 2005; 310: 329-332
11. Herkenham M, Lynn AB, de Costa BR, Richfield EK. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res 1991; 547: 267-274
12. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Cost BR, Rice KC. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 1991; 16: 8057-8066
13. Breivogel CS, Childers SR. The functional neuroanatomy of brain cannabinoid receptors. Neurobiol Dis 1998; 5: 417-431
14. Wilson RI, Nicoll RA. Endocannabinoid signaling in the brain. Science 2002; 296: 678-682
15. Mechoulam R, Ben-Shabat S, Hanus L, et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 1995; 50: 83-90.
16. Sugiura T, Kondo S, Sukagawa A, et al. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 1995; 215: 89-97.
17. Di Marzo V, Fontana A, Cadas H, et al. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 1994; 372: 686.
18. Straiker A, Mackie K. Cannabinoids, electrophysiology, and retrograde messengers: challenges for the next 5 years. AAPS J 2006; 8: E272-6.
19. Di Marzo V, Petrosino S. Endocannabinoids and the regulation of their levels in health and disease. Curr Opin Lipidol 2007; 18: 129-140 (Pubitemid 46412082)
20. Okamoto Y, Morishita J, Tsuboi K, Tonai T, Ueda N. Molecular characterization of a phospholipase D generating anandamide and its congeners. J Biol Chem 2004; 279: 5298-5305 (Pubitemid 38220550)
21. Beltramo M, Piomelli D. Carrier-mediated transport and enzymatic hydrolysis of the endogenous cannabinoid 2-arachidonylglycerol. Neuroreport 2000; 11: 1231-1235. (Pubitemid 30262964)
22. Basavarajappa BS, Saito M, Cooper TB, Hungund BL. Chronic ethanol inhibits the anandamide transport and increases extracellular anandamide levels in cerebellar granule neurons. Eur J Pharmacol 2003; 466: 73-83. (Pubitemid 36385092)
23. Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 1996; 384: 83-87
24. Deutsch DG, Glaser ST, Howell, et al. The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase. J Biol Chem 2001; 276: 6967-6973 (Pubitemid 37391991)
25. Goparaju SK, Ueda N, Taniguchi K, Yamamoto S. Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors. Biochem Pharmacol 1999; 57:417-423 (Pubitemid 29065290)
26. Dinh TP, Carpenter D, Leslie FM, et al. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci USA 2002; 99: 10819-10824 (Pubitemid 34907060)
27. Herkenham M, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice KC. Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 1990; 87: 1932-1936
28. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 1991; 11: 563-583
29. Tsou K, Brown S, Sanudo-Pena MC, Mackie K, Walker JM. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 1998; 83: 393-411. (Pubitemid 28062631)
30. Egertova M, Cravatt BF, Elphick MR. Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling. Neuroscience 2003; 119: 481-496
31. Egertova M. Giang DK, Cravatt BF, Elphick MR. A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain Proc Royal Soc Lond Biol Sci 1998; 265: 2081-2085
32. Fride E. Endocannabinoids in the central nervous system - an overview. Prostaglandins Leukot Essent Fatty Acids 2002; 66: 221-233 (Pubitemid 34743597)
33. Di Marzo V, Fontana A. Anandamide, an endogenous cannabinomimetic eicosanoid: 'killing two birds with one stone'. Prostaglandins Leukot Essent Fatty Acids 1995; 53: 1-11.
34. Palmer SL, Khanolkar AD, Makriyannis A. Natural and synthetic endocannabinoids and their structure-activity relationships. Curr Pharm Des 2000; 6: 1381-1397 (Pubitemid 30671184)
35. Koob GF, Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science 1997; 278: 52-58 (Pubitemid 27446270)
36. Hayakawa K, Mishima K, Hazekawa M, et al. Cannabidiol potentiates pharmacological effects of Delta(9)- tetrahydrocannabinol via CB(1) receptor-dependent mechanism. Brain Res 2008; 1188: 157-164
37. Fride E, Perchuk A, Hall FS, Uhl GR, Onaivi ES. Behavioral methods in cannabinoid research. Methods Mol Med 2006; 123:269-290
38. Hungund BL, Basavarajappa BS, Vadasz C, et al. Ethanol, endocannabinoids and cannabinoidergic signaling system. Alcohol Clin and Exp Res 2002; 26: 565-574 (Pubitemid 34408723)
39. Basavarajappa BS, Hungund BL. Chronic ethanol increases the cannabinoid receptor agonist, anandamide and its precursor Narachidonyl phosphatidyl ethanolamine in SK-N-SH cells. J Neurochem 1999; 72: 522-528
40. Basavarajappa BS, Saito M, Cooper TB, Hungund BL. Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons. Biochem Biophys Acta 2000; 1535: 78-86.
41. González S, Cascio MG, Fernández-Ruiz J, Fezza F, Di Marzo V, Ramos JA. Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine. Brain Res 2002; 954: 73-81. (Pubitemid 35223443)
42. Basavarajappa BS, Saito M, Cooper TB, Hungund BL. Activation of arachidonic acid-specific phospholipase A2 in human neuroblastoma cells after chronic alcohol exposure: prevention by GM1 ganglioside. Alcohol Clin Exp Res 1997; 21: 1199-1203 (Pubitemid 27446886)
43. González S, Valenti M, Miguel R, et al. Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse. Brit J Pharmacol 2004;143: 455-464 (Pubitemid 39452213)
44. Vinod KY, Yalamanchili R, Xie S, Cooper TB, Hungund BL. Effect of chronic ethanol exposure and its withdrawal on the endocannabinoid system. Neurochem Int 2006; 49: 619-625 (Pubitemid 44528092)
45. Ferrer B, Bermúdez-Silva FJ, Bilbao A, et al. Regulation of brain anandamide by acute administration of ethanol. Biochem J 2007; 404: 97-104.
46. Rubio M, McHugh D, Fernández-Ruiz J, Bradshaw H, Walker JM. Short-term exposure to alcohol in rats affects brain levels of anandamide,other N-acylethanolamines and 2 arachidonoylglycerol. Neurosci Lett 2007; 421: 270-274 (Pubitemid 46935368)
47. Rubio M, de Miguel R, Fernández-Ruiz J, Gutiérrez- López D, Carai MA, Ramos JA. Effects of a short-term exposure to alcohol in rats on FAAH enzyme and CB1 receptor in different brain areas. Drug Alcohol Depend 2009; 99: 354-358
48. Basavarajappa BS, Cooper TB, Hungund BL. Chronic ethanol administration down-regulates cannabinoid receptors in mouse brain synaptic plasma membrane. Brain Res 1998; 793: 212-218
49. 35S]GTPγS binding in synaptic plasma membrane from chronic ethanol exposed mouse. Brain Res 1999;815: 89-97.
50. Oliva JM, Ortiz S, Pérez-Rial S, Manzanares J. Time dependent alterations on tyrosine hydroxylase, opioid and cannabinoid CB1 receptor gene expressions after acute ethanol administration in the rat brain. Eur Neuropsychopharmacol 2008; 18: 373-382
51. Ortiz S, Oliva JM, Perez-Rial S, Palomo T, Manzanares J. Chronic ethanol consumption regulates cannabinoid CB1 receptor gene expression in selected regions of rat brain. Alcohol Alcohol 2004;39: 88-92. (Pubitemid 38386881)
52. Mitrirattanakul S, López-Valdés HE, Liang J, et al. Bidirectional alterations of hippocampal cannabinoid 1 receptors and their endogenous ligands in a rat model of alcohol withdrawal and dependence. Alcohol Clin Exp Res 2007; 31: 855-867 (Pubitemid 46587662)
53. Gonzalez S, Fernandez-Ruiz J, Sparpaglione V, Parolaro D, Ramos JA. Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels. Drug Alcohol Depend 2002; 66: 77-84.
54. Naassila M, Pierrefiche O, Ledent C, Daoust M. Decreased alcohol self-administration and increased alcohol sensitivity and withdrawal in CB1 receptor knockout mice. Neuropharmacology 2004; 46: 243-253 (Pubitemid 37532832)
55. Vinod KY, Yalamanchili R, Thanos PK, et al. Genetic and pharmacological manipulations of the CB(1) receptor alter ethanol preference and dependence in ethanol preferring and nonpreferring mice. Synapse 2008; 62: 574-581
56. Vinod KY, Sanguino E, Yalamanchili R, Manzanares J, Hungund BL. Manipulation of fatty acid amide hydrolase functional activity alters sensitivity and dependence to ethanol. J Neurochem 2008;104: 233-243 (Pubitemid 350265054)
57. Lemos JI, Takahashi RN, Morato GS. Effects of SR141716 and WIN 55, 212-2 on tolerance to ethanol in rats using the acute and rapid procedures. Psychopharmacology 2007; 194: 139-149
58. Nowak KL, Vinod KY, Hungund BL. Pharmacological manipulation of CB1 receptor function alters development of tolerance to alcohol. Alcohol Alcohol 2006; 41: 24-32.
59. Serra S, Brunetti G, Pani M, et al. Blockade by the cannabinoid CB1 receptor antagonist, SR 141716, of alcohol deprivation effect in alcohol-preferring rats. Eur J Pharmacol 2002; 443: 95-97 (Pubitemid 34603602)
60. Rubio M, Fernández-Ruiz J, de Miguel R, et al. CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats. Neuropharmacology 2008; 54: 976-988
61. López-Moreno JA, González-Cuevas G, Rodríguez de Fonseca F, Navarro M. Long-lasting increase of alcohol relapse by the cannabinoid receptor agonist WIN 55, 212-2 during alcohol deprivation. J Neurosci 2004; 24: 8245-8252 (Pubitemid 39280804)
62. Racz I, Bilkei-Gorzo A, Toth ZE, Michel K, Palkovits M, Zimmer A. A critical role for the cannabinoid CB1 receptors in alcohol dependence and stress-stimulated ethanol drinking. J Neurosci 2003; 23: 2453-2458 (Pubitemid 36368934)
63. Schmidt LG, Samochowiec J, Finckh U, et al. Association of a CB1 cannabinoid receptor gene (CNR1) polymorphism with severe alcohol dependence. Drug Alcohol Depend 2002; 65: 221-224 (Pubitemid 34159069)
64. Blednov Y, Cravatt BF, Boehm SL, Walker D, Harris RA. Role of endocannabinoids in alcohol consumption and intoxication: Studies of mice lacking fatty acid amide hydrolase. Neuropsychopharmacology 2007; 32: 1570-1582 (Pubitemid 46920151)
65. De Witte P, Pinto E, Ansseau M, Verbanck P. Alcohol and withdrawal: from animal research to clinical issues. Neurosci Biobehav Rev 2003; 27: 189-197 (Pubitemid 36677428)
66. Maneuf YP, Nash JE, Crossman AR, Brotchie JM. Activation of the cannabinoid receptor by delta 9-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidus. Eur J Pharmacol 1996; 308: 161-164
67. Romero J, de Miguel R, Ramos JA, Fernández-Ruiz JJ. The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake. Life Sci 1998; 62: 351-356 (Pubitemid 28018188)
68. Schlicker E, Kathmann M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol Sci 2001; 22:565-572 (Pubitemid 33042646)
69. Heilig M, Egli M. Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. Pharmacol Ther 2006; 111: 855-876 (Pubitemid 44118437)
70. Hampson AJ, Bornheim LM, Scanziani M, et al. Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission. J Neurochem 1998; 70: 671-676 (Pubitemid 28079356)
71. Hayase T, Yamamoto Y, Yamamoto K. Protective effects of cannabinoid receptor agonists against cocaine and other convulsant-induced toxic behavioural symptoms. J Pharm Pharmacol 2001; 53:1525-1532 (Pubitemid 33064542)
72. Solbrig MV, Adrian R, Beretta J, Piomelli D, Giuffrida A. A role for endocannabinoids in viral-induced dyskinetic and convulsive phenomena. Exp Neurol 2005; 194: 355-362 (Pubitemid 40966995)
73. Chester JA, Blose AM, Froehlich JC. Further evidence of an inverse genetic relationship between innate differences in alcohol preference and alcohol withdrawal magnitude in multiple selectively bred rat lines. Alcohol Clin Exp Res 2003; 27: 377-387
74. Wallace MJ, Martin BR, DeLorenzo RJ. Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. Eur J Pharmacol 2002; 452: 295-301.
75. Arnone M, Maruani J, Chaperon F, et al. Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology 1997; 132:104-106 (Pubitemid 27303746)
76. Colombo G, Agabio R, Fa M, et al. Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR-141716. Alcohol Alcohol 1998; 33: 126-130 (Pubitemid 28161888)
77. Gallate JE, McGregor IS. The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716. Psychopharmacology 1999;142: 302-308
78. Gallate JE, Mallet PE, McGregor IS. Combined low dose treatment with opioid and cannabinoid receptor antagonists synergistically reduces the motivation to consume alcohol in rats. Psychopharmacology (Berl) 2004; 173: 210-216
79. Rodriguez de Fonseca F, Roberts AJ, Bilbao A, Koob GF, M N. Cannabinoid receptor antagonist SR141716A decreases operant ethanol self administration in rats exposed to ethanol-vapor chambers. Acta Pharmacol Sin 1999; 20: 1109-1114
80. Lallemand F, Soubrié PH, De Witte PH. Effects of CB1 cannabinoid receptor blockade on ethanol preference after chronic ethanol administration. Alcohol Clin Exp Res 2001; 25: 1317-1323 (Pubitemid 32868340)
81. Freedland CS, Sharpe AL, Samson HH, Porrino LJ. Effects of SR141716A on ethanol and sucrose self-administration. Alcohol Clin Exp Res 2001; 25: 277-282
82. Hansson AC, Bermudez-Silva FJ, Malinen H, et al. Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference. Neuropsychopharmacology 2007; 32: 117-126 (Pubitemid 44967790)
83. Gallate JE, Saharov T, Mallet P, McGregor IS. Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist. Eur J Pharmacol 1999; 370:233-240 (Pubitemid 29192867)
84. Kelaï S, Hanoun N, Aufrère G, Beaugé F, Hamon M, Lanfumey L. Cannabinoid-serotonin interactions in alcohol-preferring vs alcohol-avoiding mice. J Neurochem 2006; 99: 308-320 (Pubitemid 44395153)
85. Hungund BL, Szakall I, Adam A, Basavarajappa BS, Vadasz C. Cannabinoid CB1 receptor-knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens. J Neurochem 2003;84: 698-704. (Pubitemid 36176928)
86. Wang L, Liu J, Harvey-white J, Zimmer A, Kunos G. Endocannabinoid signaling via CB1 receptors is involved in ethanol preference and its age-dependent decline in mice. Proc Natl Acad Sci USA 2003; 100: 1393-1398 (Pubitemid 36184012)
87. Thanos PK, Dimitrakakis ES, Rice O, Gifford A, Volkow ND. Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors. Behav Brain Res 2005; 164: 206-213 (Pubitemid 41337875)
88. Poncelet M, Maruani J, Calassi R, Soubrie P. Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice. Neurosci Lett 2003; 343: 216-218 (Pubitemid 38365988)
89. Houchi H, Babovic D, Pierrefiche O, Ledent C, Daoust M, Naassila M. CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors. Neuropsychopharmacology 2005; 30: 339-349 (Pubitemid 40129485)
90. Hungund BL, Basavarajappa BS. Distinct differences in the cannabinoid receptor density and affinity in the brains of C57BL/6 and DBA/2 inbred mice strains and their significance in differences in ethanol drinking behavior. J Neurosci Res 2000; 60: 122-128
91. Cravatt BF, Demarest K, Patricelli MP, et al. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci USA 2001; 98: 9371-9376 (Pubitemid 32743923)
92. Basavarajappa BS, Yalamanchili R, Cravatt BF, Cooper TB, Hungund BL. Increased ethanol consumption and preference and decreased ethanol sensitivity in female FAAH knockout mice. Neuropharmacology 2006; 50: 834-844 (Pubitemid 43737004)
93. Cippitelli A, Cannella N, Braconi S, et al. Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat. Psychopharmacology 2008;198: 449-460
94. Solinas M, Justinova J, Goldberg SR, Tanda GJ. Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rat. J Neurochem 2006; 98: 408-419 (Pubitemid 44133146)
95. Sipe JC, Chiang K, Gerber AL, Beutler E, Cravatt BF. A missense mutation in human fatty acid amide hydrolase associated with problem drug use. Proc Natl Acad Sci USA 2002; 99: 8394-8399 (Pubitemid 34651063)
96. Chiang KP, Gerber AL, Sipe JC, Cravatt BF. Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use. Hum Mol Genet 2004; 13: 2113-2119
97. Koob GF. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 1992; 13: 177-184
98. Tanda G, Loddo P, Di Chiara G. Dependence of mesolimbic dopamine transmission on delta9-tetrahydrocannabinol. Eur J Pharmacol 1999; 376: 23-26 (Pubitemid 29320166)
99. Fadda F, Rossetti ZL. Chronic ethanol consumption: from neuroadaptation to neurodegeneration. Prog Neurobiol 1998; 56: 385-431. (Pubitemid 28404897)
100. Koob GF, Roberts AJ. Brain reward circuits in alcoholism. CNS Spectr 1999; 4: 23-37.
101. Routtenberg A. Self-stimulation pathways: origins and terminations- A three stage technique. In: Wauquier A, Rolls ET, Eds. Brain-stimulation Reward. Amsterdam: Elsevier/North Holland Biochemical Press 1976; p. 31.
102. Childers SR, Deadwyler SA. Role of cyclic AMP in the actions of cannabinoid receptors. Biochem Pharmacol 1996; 52: 819-827 (Pubitemid 26301881)
103. Brado MT. Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens. Crit Rev Neurobiol 1998; 12: 36-67.
104. Colombo G, Serra S, Brunetti G, et al. Stimulation of voluntary ethanol intake by cannabinoid receptor agonists in ethanol preferring sP rats. Psychopharmacology 2002; 159: 181-187 (Pubitemid 34146562)